Vamotinib and its Impurities
Vamotinib is a tyrosine kinase inhibitor developed for the treatment of leukemia, targeting BCR-ABL mutations to overcome resistance to earlier-generation therapies. Reference standards of Vamotinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
3-([1,2,4]Triazolo[4,3-a]pyridin-3-ylethynyl)-4-methyl-N-(4-(piperazin-1-ylmethyl)-3-(trifluoromethyl)phenyl)benzamide
3-([1,2,4]Triazolo[4,3-a]pyridin-3-ylethynyl)-4-methyl-N-(4-(piperazin-1-ylmethyl)-3-(trifluoromethyl)phenyl)benzamide
Catalogue No.:PA 22 1291000
CAS :
1488421-25-5
Molecular Formula : C28H25F3N6O
Molecular Weight : 518.54
